Company / Operating Income
CAPRICOR THERAPEUTICS, INC. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$108.1M
FY2025
5-year range
-$108.1M / -$20.9M
FY2021-FY2025
Trend
-154.1%
vs FY2024
Sector context
#96 of 204
Health Care
What the data says
At -$108M, CAPRICOR THERAPEUTICS, INC.'s operating income ranks #96 of 204 in the Health Care sector. Operating Income has fluctuated over the past 10 years, ranging from -$108M in FY2025 to -$13M in FY2017.
Based on SEC 10-K filings.
-$108M in FY2025.
Declined from -$24M to -$108M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#96 of 204 in Health CareTop 47% of 204This company -$108.1M Sector average $107.7M
▼
-200.4% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 154.1% year-over-year.
- Ranks #96 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$108.1M | -154.1% |
| FY2024 | -$42.6M | -76.8% |
| FY2023 | -$24.1M | +18.9% |
| FY2022 | -$29.7M | -41.8% |
| FY2021 | -$20.9M | -52.9% |
| FY2020 | -$13.7M | +10.7% |
| FY2019 | -$15.3M | +0.0% |
| FY2018 | -$15.3M | -19.2% |
| FY2017 | -$12.9M | +24.2% |
| FY2016 | -$17.0M | -34.6% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026